Benzinga's Top Upgrades

By: via Benzinga
Analysts at UBS upgraded PharMerica Corporation (NYSE: PMC) from Neutral to Buy. The target price for Pharmerica has been raised from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.